FORMELA JEAN FRANCOIS sold $2.5M of KRRO (indirect holdings)
FORMELA JEAN FRANCOIS sold 171,405 indirectly-held shares of Korro Bio, Inc. (KRRO) at an average of $14.34 ($13.95–$14.98, $2.46M total) across 8 trades over 2026-06-22 to 2026-06-24 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale by a director can modestly influence short-term sentiment, but it is not presented alongside any new clinical, regulatory, or financial development.
Market read
Traders may monitor KRRO for follow-on insider activity, but the filing alone is unlikely to drive a major repricing without additional catalysts.
What to watch
The article does not state whether the director’s total holdings changed materially beyond the post-transaction figure, nor does it provide context on prior sales frequency.
Background
The article is an SEC Form 4 insider transaction disclosure for Korro Bio, Inc.
Ticker impact
Korro Bio director Formela Jean Francois sold $2.46M of KRRO shares via an open-market sale under a 10b5-1 plan (171,405 shares).
Likely limited near-term impact; any effect should be small and fade unless accompanied by other company-specific news.
The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and no accompanying operational/financial update in the text.
Market effects
No sector read-through provided; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerKorro Bio, Inc.
Subject of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.
- insiderFORMELA JEAN FRANCOIS
Director who executed the open-market sale of KRRO shares.